Evidence map›Paper›PMID 41909900›Full record

ArticleGut microbes reports2025

Addressing the global challenge of

Patrick Ashinze, Simran Karkhanis, Babas Puamus Oki, Chibueze Francis Ngirigwa, Matthew Olamide Olaniyan, Aishat Oluyole, Samuel Olatunji, Aliyu Mansa Aminu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut microbes reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Patrick AshinzeFaculty of Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.ORCID https://orcid.org/0009-0007-9137-5498
Simran KarkhanisSchool of Medicine and Dentistry, University of Central Lancashire, Preston, UK.ORCID https://orcid.org/0009-0007-4522-4576
Babas Puamus OkiI. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.ORCID https://orcid.org/0009-0007-6919-835X
Chibueze Francis NgirigwaFaculty of Clinical Sciences, Madonna University, Elele, Nigeria.ORCID https://orcid.org/0009-0008-4566-4501
Matthew Olamide OlaniyanFaculty of Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.ORCID https://orcid.org/0009-0007-2605-070X
Aishat OluyoleFaculty of Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.ORCID https://orcid.org/0009-0008-2180-520X
Samuel OlatunjiFaculty of Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.ORCID https://orcid.org/0009-0006-7764-5431
Aliyu Mansa AminuNottingham Trent University, Nottingham, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic resistancedyspepsiahealth equityHelicobacter pyloripeptic ulcer diseasequadruple therapy

Identifiers

PMID41909900
PMCPMC12940100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.